… including radiomics and digital pathology, individual risk-stratified neoadjuvant treatment
approaches are poised to make a striking impact on the outcomes of early-stage NSCLC. …

… Changes in primary tumors provide a reliable way to assess the impact of neoadjuvant
treatment on an individual’s tumor and presents an opportunity to change the induction regimen …

… of neoadjuvant therapy for stage IlIb non-small cell lung cancer within the context of a larger
trial aimed at identifying a treatment … initial impression that neoadjuvant treatment is feasible, …

… aim of neoadjuvant treatment in non-small cell lung cancer (NSCLC) is to eliminate
micrometastatic disease to facilitate surgical resection. Neoadjuvant … treatment in resectable …

… treatment of locally advanced non-small cell lung cancer. To assess the postoperative morbidity
and mortality associated with aggressive neoadjuvant … -small cell lung cancer after two …

… the optimal treatment scenario a matter of intense debate. In this review, we summarize the
main results concerning treatment sequencing in resectable non–small cell lung cancer from …

… neoadjuvant routine because it is better tolerated and can be administered in an outpatient
setting [lo]. A truly effective neoadjuvant … radiation to the ”standard treatment group” was not in …

… Here we further summarize the safety and efficacy of various neoadjuvant treatment
regimens including immunotherapy from ongoing clinical trials and elaborate the role of …

… lung cancer is 20% for Stage IIIA and 8% for Stage IIIB (3), Between 1981 and 1984, a
neoadjuvant … partial and 31% minimal responses) after neoadjuvant CAP and 90% of potentially …

… Patients in the dCRT group received the same neoadjuvant treatment as described above.
Patients treated with neoadjuvant CRT or CHT who presented a radiological response to the …